Sutro Biopharma IncNASDAQ:STRO
- LAST PRICE4.1500
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots4.0900/ 2
- Ask / Lots4.4000/ 10
- Open / Previous Close4.0000 / 4.1500
- Day Range
- 52 Week Range
- Volume578,656
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | STRO |
|---|---|---|
| 09:32 ET | 9770 | 4.025 |
| 09:34 ET | 8947 | 4.06 |
| 09:36 ET | 6827 | 4.04 |
| 09:38 ET | 7000 | 4.06 |
| 09:39 ET | 5916 | 4.06 |
| 09:41 ET | 2711 | 4.06 |
| 09:43 ET | 15788 | 4.04 |
| 09:45 ET | 10925 | 4 |
| 09:48 ET | 2800 | 4.005 |
| 09:50 ET | 7857 | 4.01 |
| 09:52 ET | 2038 | 3.9605 |
| 09:54 ET | 1900 | 3.94 |
| 09:56 ET | 300 | 3.95 |
| 09:57 ET | 400 | 3.96 |
| 09:59 ET | 3100 | 3.975 |
| 10:01 ET | 825 | 4 |
| 10:03 ET | 900 | 4 |
| 10:06 ET | 3225 | 4 |
| 10:08 ET | 2600 | 4.02 |
| 10:10 ET | 4792 | 4.03 |
| 10:12 ET | 1277 | 4.02 |
| 10:14 ET | 100 | 4.03 |
| 10:15 ET | 800 | 4.045 |
| 10:17 ET | 1100 | 4.05 |
| 10:19 ET | 2325 | 4.055 |
| 10:21 ET | 2034 | 4.04 |
| 10:24 ET | 849 | 4.065 |
| 10:26 ET | 300 | 4.055 |
| 10:28 ET | 488 | 4.085 |
| 10:30 ET | 1700 | 4.085 |
| 10:32 ET | 1543 | 4.08 |
| 10:33 ET | 200 | 4.09 |
| 10:35 ET | 900 | 4.0906 |
| 10:39 ET | 400 | 4.095 |
| 10:42 ET | 2600 | 4.085 |
| 10:44 ET | 400 | 4.085 |
| 10:46 ET | 800 | 4.085 |
| 10:48 ET | 1800 | 4.08 |
| 10:50 ET | 300 | 4.085 |
| 10:51 ET | 300 | 4.085 |
| 10:53 ET | 1900 | 4.085 |
| 10:55 ET | 500 | 4.085 |
| 10:57 ET | 2100 | 4.085 |
| 11:00 ET | 400 | 4.085 |
| 11:02 ET | 5024 | 4.07 |
| 11:04 ET | 1900 | 4.04 |
| 11:06 ET | 5500 | 4.045 |
| 11:08 ET | 5944 | 4.07 |
| 11:09 ET | 4800 | 4.08 |
| 11:11 ET | 6400 | 4.0701 |
| 11:13 ET | 4400 | 4.085 |
| 11:15 ET | 4000 | 4.0849 |
| 11:20 ET | 9082 | 4.0601 |
| 11:24 ET | 2400 | 4.08 |
| 11:26 ET | 1805 | 4.105 |
| 11:27 ET | 1391 | 4.095 |
| 11:29 ET | 200 | 4.095 |
| 11:31 ET | 100 | 4.095 |
| 11:33 ET | 1600 | 4.09 |
| 11:36 ET | 700 | 4.1 |
| 11:38 ET | 900 | 4.11 |
| 11:40 ET | 100 | 4.115 |
| 11:42 ET | 3500 | 4.115 |
| 11:44 ET | 3964 | 4.1 |
| 11:45 ET | 200 | 4.105 |
| 11:47 ET | 533 | 4.085 |
| 11:49 ET | 500 | 4.09 |
| 11:51 ET | 500 | 4.115 |
| 11:56 ET | 600 | 4.115 |
| 11:58 ET | 1550 | 4.12 |
| 12:02 ET | 404 | 4.13 |
| 12:03 ET | 100 | 4.125 |
| 12:05 ET | 1016 | 4.11 |
| 12:07 ET | 1600 | 4.1 |
| 12:09 ET | 990 | 4.11 |
| 12:12 ET | 300 | 4.115 |
| 12:14 ET | 2595 | 4.138 |
| 12:16 ET | 1400 | 4.135 |
| 12:18 ET | 300 | 4.135 |
| 12:21 ET | 705 | 4.1358 |
| 12:23 ET | 309 | 4.1349 |
| 12:25 ET | 11700 | 4.1301 |
| 12:27 ET | 13875 | 4.105 |
| 12:30 ET | 5200 | 4.105 |
| 12:32 ET | 507 | 4.105 |
| 12:34 ET | 100 | 4.105 |
| 12:36 ET | 800 | 4.1 |
| 12:38 ET | 300 | 4.1 |
| 12:39 ET | 487 | 4.105 |
| 12:41 ET | 400 | 4.105 |
| 12:43 ET | 996 | 4.105 |
| 12:45 ET | 5922 | 4.1 |
| 12:48 ET | 2300 | 4.1093 |
| 12:50 ET | 4002 | 4.12 |
| 12:52 ET | 500 | 4.119 |
| 12:56 ET | 600 | 4.115 |
| 12:57 ET | 200 | 4.115 |
| 01:01 ET | 200 | 4.115 |
| 01:03 ET | 100 | 4.115 |
| 01:06 ET | 100 | 4.115 |
| 01:08 ET | 200 | 4.11 |
| 01:10 ET | 365 | 4.115 |
| 01:12 ET | 200 | 4.115 |
| 01:14 ET | 200 | 4.115 |
| 01:15 ET | 100 | 4.12 |
| 01:19 ET | 200 | 4.115 |
| 01:21 ET | 11175 | 4.105 |
| 01:24 ET | 200 | 4.105 |
| 01:26 ET | 300 | 4.105 |
| 01:28 ET | 2646 | 4.105 |
| 01:30 ET | 1200 | 4.105 |
| 01:32 ET | 900 | 4.105 |
| 01:33 ET | 19036 | 4.075 |
| 01:35 ET | 7372 | 4.085 |
| 01:39 ET | 1542 | 4.085 |
| 01:42 ET | 6875 | 4.13 |
| 01:44 ET | 100 | 4.125 |
| 01:46 ET | 100 | 4.13 |
| 01:48 ET | 391 | 4.125 |
| 01:50 ET | 100 | 4.125 |
| 01:51 ET | 359 | 4.13 |
| 01:53 ET | 2325 | 4.14 |
| 01:55 ET | 143 | 4.145 |
| 01:57 ET | 729 | 4.145 |
| 02:00 ET | 4394 | 4.15 |
| 02:02 ET | 1700 | 4.16 |
| 02:04 ET | 600 | 4.155 |
| 02:06 ET | 886 | 4.155 |
| 02:08 ET | 243 | 4.155 |
| 02:09 ET | 200 | 4.155 |
| 02:11 ET | 343 | 4.1575 |
| 02:13 ET | 706 | 4.16 |
| 02:15 ET | 7780 | 4.12 |
| 02:18 ET | 8200 | 4.12 |
| 02:20 ET | 600 | 4.105 |
| 02:26 ET | 2100 | 4.1 |
| 02:27 ET | 945 | 4.105 |
| 02:29 ET | 100 | 4.11 |
| 02:31 ET | 1626 | 4.12 |
| 02:33 ET | 1644 | 4.11 |
| 02:38 ET | 100 | 4.115 |
| 02:40 ET | 100 | 4.115 |
| 02:42 ET | 100 | 4.12 |
| 02:44 ET | 1000 | 4.115 |
| 02:45 ET | 100 | 4.12 |
| 02:47 ET | 679 | 4.115 |
| 02:49 ET | 3209 | 4.115 |
| 02:51 ET | 200 | 4.12 |
| 02:54 ET | 3300 | 4.14 |
| 02:56 ET | 2784 | 4.14 |
| 02:58 ET | 2203 | 4.13 |
| 03:00 ET | 100 | 4.1201 |
| 03:02 ET | 200 | 4.13 |
| 03:03 ET | 641 | 4.12 |
| 03:05 ET | 100 | 4.125 |
| 03:07 ET | 200 | 4.13 |
| 03:09 ET | 2000 | 4.14 |
| 03:12 ET | 700 | 4.14 |
| 03:14 ET | 2679 | 4.14 |
| 03:16 ET | 1225 | 4.16 |
| 03:18 ET | 100 | 4.155 |
| 03:20 ET | 600 | 4.16 |
| 03:21 ET | 3676 | 4.13 |
| 03:23 ET | 1100 | 4.13 |
| 03:25 ET | 17015 | 4.13 |
| 03:27 ET | 300 | 4.13 |
| 03:34 ET | 6439 | 4.16 |
| 03:36 ET | 1245 | 4.16 |
| 03:38 ET | 100 | 4.165 |
| 03:39 ET | 521 | 4.168 |
| 03:41 ET | 16137 | 4.165 |
| 03:43 ET | 500 | 4.165 |
| 03:45 ET | 1852 | 4.16 |
| 03:48 ET | 514 | 4.155 |
| 03:50 ET | 200 | 4.155 |
| 03:52 ET | 13425 | 4.145 |
| 03:54 ET | 19417 | 4.15 |
| 03:56 ET | 2369 | 4.165 |
| 03:57 ET | 6349 | 4.165 |
| 03:59 ET | 16170 | 4.15 |
May 15, 2024
DJ Sutro Biopharma Is Maintained at Outperform by Oppenheimer, from 11:47AM ET on Wednesday May 15, 2024 by Dow Jones
11:47AM ET on Wednesday May 15, 2024 by Dow Jones
May 14, 2024
DJ Sutro Biopharma Price Target Maintained With a $8.00/Share by Wedbush, from 8:41AM ET on Tuesday May 14, 2024 by Dow Jones
8:41AM ET on Tuesday May 14, 2024 by Dow JonesDJ Sutro Biopharma Price Target Maintained With a $12.00/Share by HC Wainwright & Co., from 7:28AM ET on Tuesday May 14, 2024 by Dow Jones
7:28AM ET on Tuesday May 14, 2024 by Dow Jones
May 13, 2024
Sutro Biopharma Reports First Quarter 2024 Financial Results, Business Highlights and Select Anticipated Milestones, from 4:30PM ET on Monday May 13, 2024 by Dow Jones
4:30PM ET on Monday May 13, 2024 by Dow Jones*DJ Sutro Biopharma 1Q Loss/Shr 95c >STRO, from 4:30PM ET on Monday May 13, 2024 by Dow Jones
4:30PM ET on Monday May 13, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Sutro Biopharma Inc | 321.3M | -2.2x | --- |
Kamada Ltd | 321.3M | 21.3x | -22.48% |
Agenus Inc | 226.4M | -0.8x | --- |
Anika Therapeutics Inc | 386.7M | -4.9x | --- |
Karyopharm Therapeutics Inc | 133.0M | -0.9x | --- |
FibroGen Inc | 118.4M | -0.5x | --- |
Company Information
Sutro Biopharma, Inc. is a clinical-stage oncology company. The Company is engaged in developing site-specific and novel-format antibody drug conjugates (ADCs) enabled by its integrated cell-free protein synthesis platform, XpressCF, and its site-specific conjugation platform, XpressCF+. The Company’s advanced product candidate is STRO-002 (luveltamab tazevibulin, or luvelta), an ADC directed against folate receptor-alpha (FolRa), for patients with FolRa-expressing cancers, including ovarian cancer. In addition, it uses luvelta to treat pediatric patients with relapsed/refractory CBFA2T3-GLIS2 and acute myeloid leukemia. It also has two preclinical product candidates, STRO-003 and STRO-004. These product candidates are single homogeneous ADCs directed against an anti-receptor tyrosine kinase-like orphan receptor 1 (ROR1), and tissue factor (TF), each of which is being developed for the treatment of solid tumors.
Contact Information
- Headquarters
- 111 Oyster Point Blvd.SOUTH SAN FRANCISCO, CA, United States 94080
- Phone
- 650-392-8412
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Connie Matsui
- President, Chief Operating Officer
- Jane Chung
- Chief Executive Officer, Director
- William Newell
- Chief Financial Officer
- Edward Albini
- Chief People and Communications Officer
- Linda Fitzpatrick
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $321.3M |
|---|---|
Revenue (TTM) | $154.1M |
Shares Outstanding | 81.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.23 |
EPS | $-1.89 |
Book Value | $2.45 |
P/E Ratio | -2.2x |
Price/Sales (TTM) | 2.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -67.27% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
